2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2764
  



  

  
Submitter : 
  

  
Mr. Calin Evon
  

  
Date & Time: 
  

  
12/08/2006 09:12:11
  



  

  
Organization : 
  

  
Lockheed Martin Corporation
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Since a majority of the successes we've read about have been from using adult stem cells, it really makes no sense to use electively aborted stem cells.  If infant stem cells are required, they can be obtained from chord stem cells obtained from natural births and not electively aborted stem cells.  Chord stem cells collected from full natural births would provide more than enough stem cells for testing and research; in fact, they would provide more for this purpose than are provided from aborted infants.